How well does supplemental screening magnetic resonance imaging work in high-risk women?

Journal of Clinical Oncology

Volumn 32, Issue 21, 2014, Pages 2193-2196

  Berg, Wendie A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLAUSTROPHOBIA; DIGITAL MAMMOGRAPHY; EDITORIAL; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HIGH RISK PATIENT; HUMAN; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY;

EID: 84905816949     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.2975     Document Type: Editorial

References (43)

1. Nelson HD, Tyne K, Naik A, et al: Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 151:727-737; W237-W242, 2009
2. Rosenberg RD, Yankaskas BC, Abraham LA, et al: Performance benchmarks for screening mammography. Radiology 241:55-66, 2006 (Pubitemid 44433335)
3. Puliti D, Duffy SW, Miccinesi G, et al: Overdiagnosis in mammographic screening for breast cancer in Europe: A literature review. J Med Screen 19:42-56, 2012 (suppl 1)
4. Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684-1689, 1990 (Pubitemid 120031871)
5. King MC: "The race" to clone BRCA1. Science 343:1462-1465, 2014
6. Chiarelli AM, Prummel MV, Muradali D, et al: Effectiveness of screening with annual magnetic resonance imaging and mammography: Results from the initial screen from the Ontario High Risk Breast Screening Program. J Clin Oncol 32:2224-2230, 2014
7. Bellcross CA, Leadbetter S, Alford SH, et al: Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral. Cancer Epidemiol Biomarkers Prev 22:728-735, 2013
8. U.S. Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann Intern Med 143:355-361, 2005
9. Nelson HD, Pappas M, Zakher B, et al: Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: A systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160, 2014 [epub ahead of print on February 18, 2014]
10. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130, 2004 (Pubitemid 38477070)
11. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007 (Pubitemid 46535708)
12. Brekelmans CT, Seynaeve C, Bartels CC, et al: Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924-930, 2001 (Pubitemid 32176266)
13. Komenaka IK, Ditkoff BA, Joseph KA, et al: The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079-2083, 2004 (Pubitemid 38580324)
14. Tilanus-Linthorst M, Verhoog L, Obdeijn IM, et al: A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 102:91-95, 2002
15. Rebbeck TR, Friebel T, Lynch HT, et al: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22:1055-1062, 2004 (Pubitemid 41095038)
16. Meijers-Heijboer H, van Geel B, van Putten WL, et al: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159-164, 2001 (Pubitemid 32662123)
17. Gahm J, Wickman M, Brandberg Y: Bilateral prophylactic mastectomy in women with inherited risk of breast cancer: Prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19:462-469, 2010
18. Warner E, Hill K, Causer P, et al: Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol 29:1664-1669, 2011
19. Kuhl CK, Schrading S, Bieling HB, et al: MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet 370:485-492, 2007 (Pubitemid 47214635)
20. Rijnsburger AJ, Obdeijn IM, Kaas R, et al: BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: Long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol 28:5265-5273, 2010
21. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365: 1769-1778, 2005 (Pubitemid 40744657)
22. Boyd NF, Guo H, Martin LJ, et al: Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236, 2007 (Pubitemid 46143226)
23. Corsetti V, Houssami N, Ghirardi M, et al: Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: Interval breast cancers at 1 year follow-up. Eur J Cancer 47:1021-1026, 2011
24. Berg WA, Zhang Z, Lehrer D, et al: Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307:1394-1404, 2012
25. Schrading S, Schild H, Kuhl C: MRI Screening of Women at Average Risk of Breast Cancer. Chicago, IL, Radiologic Society North America, 2012
26. Schrading S, Strobel K, Kuhl CK: MRI screening of women at average risk of breast cancer. Presented at the San Antonio Breast Cancer Symposium. San Antonio, TX, December 13, 2013 (abstr S1-09)
27. Kuhl CK, Schrading S, Strobel K, et al: A novel approach to screening breast MRI: MIP and FAST breast MRI (poster). Presented at the San Antonio Breast Cancer Symposium. San Antonio, TX, December 13, 2013
28. Sardanelli F, Podo F, Santoro F, et al: Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 study): Final results. Invest Radiol 46:94-105, 2011
29. Sardanelli F, Santoro F, Podo F: Screening high risk women with MRI alone? Eur J Radiol 81:S137-S138, 2012 (suppl 1)
30. Berrington de Gonzalez A, Berg CD, Visvanathan K, et al: Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst 101:205-209, 2009
31. Heijnsdijk EA, Warner E, Gilbert FJ, et al: Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21:1458-1468, 2012
32. National Comprehensive Cancer Network: Genetics Screening. http://www.nccn.org/professionals/physician-gls/pdf/genetics-screening.pdf
33. Kerlikowske K, Zhu W, Hubbard RA, et al: Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med 173:807-816, 2013
34. Hubbard RA, Kerlikowske K, Flowers CI, et al: Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: A cohort study. Ann Intern Med 155:481-492, 2011
35. Brodersen J, Siersma VD: Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 11:106-115, 2013
36. Rafferty EA, Park JM, Philpotts LE, et al: Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: Results of a multicenter, multireader trial. Radiology 266:104-113, 2013
37. Skaane P, Bandos AI, Gullien R, et al: Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 267:47-56, 2013
38. Corsetti V, Houssami N, Ferrari A, et al: Breast screening with ultrasound in women with mammography-negative dense breasts: Evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer 44:539-544, 2008
39. Berg WA, Blume JD, Adams AM, et al: Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 254:79-87, 2010
40. Lee CH, Dershaw DD, Kopans D, et al: Breast cancer screening with imaging: Recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 7:18-27, 2010
41. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
42. Lehman CD, Isaacs C, Schnall MD, et al: Cancer yield of mammography, MR, and US in high-risk women: Prospective multi-institution breast cancer screening study Radiology 244:381-388, 2007 (Pubitemid 47080869)
43. Warner E, Plewes DB, Hill KA, et al: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325, 2004 (Pubitemid 39223222)